Brussels, Belgium

Frederik E Riphagen

This inventor holds 1 USPTO granted patent. Top assignee: Schering Oy. Active years: 2007.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 124(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Frederik E. Riphagen

Introduction

Frederik E. Riphagen is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of otorhinology through his innovative inventions. His work focuses on developing advanced delivery devices that enhance the effectiveness of pharmaceutical treatments.

Latest Patents

Riphagen holds a patent for an otorhinological delivery device. This invention relates to a device that comprises at least one pharmaceutically active agent. The device features a core made of an elastomer composition, which includes materials such as poly(dimethylsiloxane) and siloxane-based elastomers. The core is encased in a membrane that may be made from the same or a different elastomer composition. The pharmaceutically active agents selected for this device include anti-allergic agents, anti-inflammatory agents, anti-fungicides, glucocorticoids, and mixtures thereof. He has 1 patent to his name.

Career Highlights

Frederik E. Riphagen is associated with Schering Oy, a company known for its focus on pharmaceutical innovations. His work at Schering Oy has allowed him to contribute to the development of cutting-edge medical devices that address various health issues.

Collaborations

Riphagen has collaborated with notable colleagues such as Timo Haapakumpu and Harri Jukarainen. These collaborations have further enhanced the impact of his inventions in the medical field.

Conclusion

Frederik E. Riphagen's contributions to the field of otorhinology through his innovative delivery device exemplify the importance of advancements in pharmaceutical technology. His work continues to influence the development of effective treatments for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…